On the contrary, another study showed that treatment of NCI-H2228, a human non-small cell lung carcinoma cell line, with CH5424802 (a selective ALK inhibitor) led to reduction in p-Akt expression (35). This evidence concerns the gene ALK and non-small cell lung carcinoma.